Advanced Biomed Inc.’s ADVB share price has dipped by 25.17%, which has investors questioning if this is right time to buy.

Additionally, mesenchymal markers like Vimentin and α-SMA were also diminished, while epithelial markers such as E-cadherin, Occludin, and ZO-1 were elevated, suggesting a disrupted EMT process.